Safety of Continuing Mineralocorticoid Receptor Antagonists Treatment in Patients with Heart Failure with Reduced Ejection Fraction and Severe Kidney Disease: Data from Swedish Heart Failure Registry.

Federica GuidettiLars H LundLina BensonCamilla HageFrancesca MusellaDavide StolfoPeter G M MolAndreas J FlammerFrank RuschitzkaUlf DahlstromGiuseppe M C RosanoOscar Ö BraunGianluigi Savarese

Published in: European journal of heart failure (2023)

The use of MRAs in patients with HFrEF decreased with worse renal function; however their safety profile was demonstrated to be consistent across the entire eGFR spectrum. This article is protected by copyright. All rights reserved.

Keyphrases

heart failure
small cell lung cancer
epidermal growth factor receptor
electronic health record
tyrosine kinase
left ventricular
atrial fibrillation
big data
combination therapy
cardiac resynchronization therapy
deep learning
data analysis